SCHEMBL3723005

SCHEMBL3723005

CC1(C)CN(Cc2ccc(-c3cncc(-c4cc(-c5ccccn5)nc(C(C)(C)O)c4)c3)cc2)CCN1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.37
KIT P10721 1/20 0.37
ABL2 P42684 1/20 0.37
TGFBR1 P36897 3/20 0.36
DRD2 P14416 2/20 0.34
DRD4 P21917 2/20 0.34
DRD3 P35462 2/20 0.34
MCHR1 Q99705 1/20 0.33
AKT1 P31749 9/20 0.33
AKT2 P31751 8/20 0.33
IDH1 O75874 1/20 0.32
MMP1 P03956 1/20 0.32
MMP9 P14780 1/20 0.32
MMP13 P45452 1/20 0.32
ADAM17 P78536 1/20 0.32
CLK2 P49760 1/20 0.32
CLK3 P49761 1/20 0.32
DYRK1A Q13627 1/20 0.32
EPHX1 P07099 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3723604 0.88 ABL1 (0.46) ABL1KITABL2TGFBR1DRD2
SCHEMBL3725181 0.85 AKT1 (0.40) ABL1KITABL2AKT1AKT2
SCHEMBL3718092 0.83 DRD2 (0.41) ABL1KITABL2TGFBR1DRD2
SCHEMBL3801968 0.82 AKT1 (0.39) TGFBR1AKT1AKT2CYP2D6
SCHEMBL3716702 0.82 DRD2 (0.40) ABL1KITABL2TGFBR1DRD2
SCHEMBL3715980 0.82 ACVR1 (0.41) ABL1KITABL2TGFBR1DRD2
SCHEMBL3719755 0.78 TBK1 (0.44) MCHR1
SCHEMBL3725367 0.75 DRD2 (0.41) ABL1KITABL2TGFBR1DRD2
SCHEMBL3719903 0.73 DRD2 (0.40) TGFBR1DRD2DRD4DRD3
SCHEMBL3725755 0.73 ABL1 (0.48) ABL1KITABL2TGFBR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2242742-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2015-12-02 EP disclosed
US-8343966-B2 Organic compounds NOVARTIS AG (CH) 2013-01-01 US disclosed
EP-2242742-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2010-10-27 EP disclosed
WO-2009087212-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2009-07-16 WO disclosed